FOLD – amicus therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

FOLD

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/6

04:17 pm

fold

Rating for FOLD

Low Report

Rating for FOLD

Report

11/5

11:49 am

fold

Rating for FOLD

Low Report

Rating for FOLD

Report

11/5

11:49 am

fold

Rating for FOLD

Low Report

Rating for FOLD

Report

11/5

11:49 am

fold

Rating for FOLD

Low Report

Rating for FOLD

Report

9/18

08:09 am

fold

Amicus Therapeutics (NASDAQ:FOLD) was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating. They now have a $14.00 price target on the stock.

Low Report

Amicus Therapeutics (NASDAQ:FOLD) was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating. They now have a $14.00 price target on the stock.

Report

9/18

05:57 am

fold

Rating for FOLD

Low Report

Rating for FOLD

Report

9/18

05:57 am

fold

Rating for FOLD

Low Report

Rating for FOLD

Report

9/18

05:50 am

fold

Amicus upgraded to Buy from Hold at Needham

Medium Report

Amicus upgraded to Buy from Hold at Needham

Report

9/18

05:50 am

fold

Amicus upgraded to Buy from Hold at Needham

Medium Report

Amicus upgraded to Buy from Hold at Needham

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.